Skip Nav Destination
Issues
15 December 2005
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Editor's Note
Molecular Pathways
The Biology Behind
Human Cancer Biology
Combination Analysis of Activator Protein-1 Family Members, Sp1 and an Activator Protein-2α-Related Factor Binding to Different Regions of the Urokinase Receptor Gene in Resected Colorectal Cancers
Denis Martin Schewe; Tobias Biller; Gabriele Maurer; Irfan A. Asangani; Joerg H. Leupold; Ernst R. Lengyel; Stefan Post; Heike Allgayer
Perturbation of the Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Cascade in Ovarian Cancer: Overexpression of FLIPL and Deregulation of the Functional Receptors DR4 and DR5
Peter Horak; Dietmar Pils; Alexandra Kaider; Alexander Pinter; Katarzyna Elandt; Cornelia Sax; Christoph C. Zielinski; Reinhard Horvat; Robert Zeillinger; Alexander Reinthaller; Michael Krainer
Two Single-Nucleotide Polymorphisms with Linkage Disequilibrium in the Human Programmed Cell Death 5 Gene 5′ Regulatory Region Affect Promoter Activity and the Susceptibility of Chronic Myelogenous Leukemia in Chinese Population
Xi Ma; Guorui Ruan; Ying Wang; Qiyan Li; Ping Zhu; Ya-Zhen Qin; Jin-Lan Li; Yan-Rong Liu; Dalong Ma; Hongshan Zhao
Imaging, Diagnosis, Prognosis
Mcl-1, Vascular Endothelial Growth Factor-R2, and 14-3-3σ Expression Might Predict Primary Response against Radiotherapy and Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinomas of the Head and Neck
Boban M. Erovic; Martina Pelzmann; Matthäus Ch. Grasl; Johannes Pammer; Gabriela Kornek; Werner Brannath; Edgar Selzer; Dietmar Thurnher
Expression of Multidrug Resistance–Associated Proteins Predicts Prognosis in Childhood and Adult Acute Lymphoblastic Leukemia
Sabine L.A. Plasschaert; Eveline S.J.M. de Bont; Marike Boezen; Dorina M. vander Kolk; Simon M.J.G. Daenen; Klaas Nico Faber; Willem A. Kamps; Elisabeth G.E. de Vries; Edo Vellenga
Cancer Therapy: Clinical
Epithelial versus Mesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients
Robert L. Yauch; Thomas Januario; David A. Eberhard; Guy Cavet; Wenjing Zhu; Ling Fu; Thinh Q. Pham; Robert Soriano; Jeremy Stinson; Somasekar Seshagiri; Zora Modrusan; Chin-Yu Lin; Vincent O'Neill; Lukas C. Amler
Serum Free Light Chain Analysis and Urine Immunofixation Electrophoresis in Patients with Multiple Myeloma
Mohammad R. Nowrousian; Dieter Brandhorst; Christiane Sammet; Michaela Kellert; Rainer Daniels; Philipp Schuett; Miriam Poser; Siemke Mueller; Peter Ebeling; Anja Welt; Arthur R. Bradwell; Ulrike Buttkereit; Bertram Opalka; Michael Flasshove; Thomas Moritz; Siegfried Seeber
Feasibility and Tolerability of Sequential Doxorubicin/Paclitaxel Followed by Cyclophosphamide, Methotrexate, and Fluorouracil and Its Effects on Tumor Response as Preoperative Therapy
Luca Gianni; José Baselga; Wolfgang Eiermann; Vicente Guillem Porta; Vladimir Semiglazov; Aña Lluch; Milvia Zambetti; Dolores Sabadell; Günther Raab; Antonio Llombart Cussac; Alla Bozhok; Angel Martinez-Agulló; Marco Greco; Mikhail Byakhov; Juan Josè Lopez Lopez; Mauro Mansutti; Pinuccia Valagussa; Gianni Bonadonna; European Cooperative Trial in Operable Breast Cancer Study Group
Phase I and Pharmacokinetic Study of Sequences of the Rebeccamycin Analogue NSC 655649 and Cisplatin in Patients with Advanced Solid Tumors
Alejandro D. Ricart; Lisa A. Hammond; John G. Kuhn; Chris H. Takimoto; Andrew Goetz; Bahram Forouzesh; Leonardo Forero; Jose L. Ochoa-Bayona; Kristin Berg; Anthony W. Tolcher; Eric K. Rowinsky
Cancer Therapy: Preclinical
Antitumor Efficacy of Capecitabine and Celecoxib in Irradiated and Lead-Shielded, Contralateral Human BxPC-3 Pancreatic Cancer Xenografts: Clinical Implications of Abscopal Effects
Carmelo Blanquicett; M. Wasif Saif; Donald J. Buchsbaum; Mohamad Eloubeidi; Selwyn M. Vickers; David C. Chhieng; Mark D. Carpenter; Jeffrey C. Sellers; Suzanne Russo; Robert B. Diasio; Martin R. Johnson
Antitumor Vascular Strategy for Controlling Experimental Metastatic Spread of Human Small-Cell Lung Cancer Cells with ZD6474 in Natural Killer Cell–Depleted Severe Combined Immunodeficient Mice
Seiji Yano; Hiroaki Muguruma; Yuka Matsumori; Hisatsugu Goto; Emiko Nakataki; Nobutaka Edakuni; Hideki Tomimoto; Soji Kakiuchi; Akihiko Yamamoto; Hisanori Uehara; Anderson Ryan; Saburo Sone
T-Cell Responses Directed against Multiple HLA-A*0201-Restricted Epitopes Derived from Wilms' Tumor 1 Protein in Patients with Leukemia and Healthy Donors: Identification, Quantification, and Characterization
Katayoun Rezvani; Jason M. Brenchley; David A. Price; Yasemin Kilical; Emma Gostick; Andrew K. Sewell; Jongming Li; Stephan Mielke; Daniel C. Douek; A. John Barrett
Increased Nuclear Localization of Transcription Factor Y-Box Binding Protein 1 Accompanied by Up-Regulation of P-glycoprotein in Breast Cancer Pretreated with Paclitaxel
Tomoyuki Fujita; Ken-ichi Ito; Hiroto Izumi; Morihiko Kimura; Muneaki Sano; Hiroshi Nakagomi; Kazuma Maeno; Yoshihisa Hama; Kiyoshi Shingu; Shin-ichi Tsuchiya; Kimitoshi Kohno; Minoru Fujimori
Dual Promoter–Controlled Oncolytic Adenovirus CG5757 Has Strong Tumor Selectivity and Significant Antitumor Efficacy in Preclinical Models
Yuanhao Li; Neeraja Idamakanti; Trini Arroyo; Steve Thorne; Tony Reid; Scott Nichols; Melinda VanRoey; Gail Colbern; Natalie Nguyen; Orlena Tam; Peter Working; De-Chao Yu
Enhancement of Sensitivity to Tumor Necrosis Factor α in Non–Small Cell Lung Cancer Cells with Acquired Resistance to Gefitinib
Koichi Ando; Tohru Ohmori; Fumiko Inoue; Tsuyoki Kadofuku; Takamichi Hosaka; Hiroo Ishida; Takao Shirai; Kentaro Okuda; Takashi Hirose; Naoya Horichi; Kazuto Nishio; Nagahiro Saijo; Mitsuru Adachi; Toshio Kuroki
Cancer Prevention
Prediction of Colorectal Neoplasia by Quantitative Methylation Analysis of Estrogen Receptor Gene in Nonneoplastic Epithelium from Patients with Ulcerative Colitis
Keiichi Tominaga; Shigehiko Fujii; Kenichiroh Mukawa; Mikio Fujita; Kazuhito Ichikawa; Shigeki Tomita; Yasuo Imai; Kazunari Kanke; Yuko Ono; Akira Terano; Hideyuki Hiraishi; Takahiro Fujimori
Letters to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds